Teva Pharmaceutical Enterprises Co., Ltd.,   Israel

Film-coated tablets, 600 mg + 300 mg.

Tablets 1 mg.

Capsules.

Capsules.

Capsules, 25, 50, 75, 150 and 300 mg.

Capsules 0.5 mcg.

Solution for ingestion and inhalation 7.5 mg / ml.

Syrup 15 mg / 5 ml.

Tablets 30 mg.

Capsules of prolonged action 75 mg.

Tablets 5 mg and 10 mg.

Tablets, film-coated, 1 mg.

Tablets are dispersible in the oral cavity 10 mg, 15 mg, 30 mg.

Tablets 5 mg, 10 mg, 15 mg, 30 mg.

Tablets, film-coated, 10 mg, 20 mg, 40 mg and 80 mg.

Tablets are effervescent, 200 mg and 600 mg.

Film-coated tablets, 50 mg and 150 mg.

Tablets, film-coated, 450 mg.

Lyophilizate for the preparation of a solution for infusions, 500 mg or 1000 mg.

The tablets of the prolonged action, covered with a cover, 240 mg.

Syrup, 15 mg / 5 ml and 30 mg / 5 ml.

Solution for intravenous administration, 1 mg / ml.

Tablets, film-coated, 4 mg and 8 mg.

Lozenges.

Concentrate for solution for infusion, 1 mg / ml.

Drops for oral administration, 4000 IU / ml.

Tablets, film-coated, 5 mg.

Tablets, film-coated, 5 mg.

Film coated tablets 30 mg, 60 mg.

Films dispersible in the oral cavity, 50 mg and 100 mg.

Tablets, film-coated, 10 mg.

Powder for inhalation dosed 160 / 4.5 mcg / dose. 320/9 μg / dose.

Concentrate for the preparation of a solution for infusions of 4 mg / 5 ml.

Controlled-release tablets coated with a film coat, 1.5 mg.

Capsules, 2.5 mg.

Tablets, film-coated, 2.5 mg.

Tablets, film-coated, 0.625 mg + 2.5 mg, 1.25 mg + 5 mg.

Concentrate for solution for infusion, 20 mg / ml.

Tablets of 60 mg.

Lyophilizate for the preparation of a solution for infusions of 50 mg, 150 mg and 450 mg.

Tablets coated with a film coating, 75 mg.

Cream for external use 1%.

Tablets are vaginal, 10 mg + 200 mg.

Tablets, 300 mg.

Lyophilizate for the preparation of a solution for intravenous administration of 10 thousand ATPE.

A solution for subcutaneous administration of 20 mg / ml.

Tablets of prolonged action, film-coated 10 mg.

Tablets of prolonged action of 20 mg, film-coated.

Tablets of prolonged action, film-coated 40 mg.

Film coated tablets 250 mg.

Drops for oral administration 7.5 mg / ml.

Syrup, 667 mg / ml.

Film-coated tablets, 150 mg and 300 mg.

Tablets, film-coated, 500 mg.

Tablets 10 mg.

Tablets, film-coated, 250 mg.

Vaginal suppositories 150 mg, 300 mg, 900 mg:

Cream for external use 1%.

Capsules 250 mg.

Spray nasal dosed with 50 mcg / dose.

Tablets 5 mg.

7 tablets in a blister of PVC / PVDC / aluminum foil;

2 or 4 blisters together with instructions for use in cardboard pack.

10 tablets in a blister of PVC / PVDC / aluminum foil;

3 blisters together with instructions for use in a cardboard bundle.

Capsules 0.6 mg.

Tablets, film-coated 10 mg, 20 mg.

Concentrate for solution for infusion, 5 mg / ml.

Tablets, film-coated, 5 mg, 10 mg.

Tablets 8 mg, 16 mg, 32 mg.

The film-coated tablets are 200 mg and 400 mg.

Tablets, film-coated, 2.5 mg. 5 mg and 10 mg.

For 30 tablets in a white polypropylene container with a polyethylene lid with a drying insert, equipped with a polyethylene limiter with the control of the first opening.

1 The container together with instructions for use in a cardboard bundle.

Lyophilizate for the preparation of a solution for intravenous administration, 2.0 g + 0.25 g and 4.0 g + 0.5 g.

Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 1 mg.

Tablets, dispersible in the oral cavity 2 mg.

Capsules, 500 mg.

Nasal drops 0.05% and 0.1%.

10 ml of the preparation in a bottle of brown glass, equipped with a dropper SANO with a cap of polyethylene and a security tape control the first opening. One bottle is placed in a cardboard box along with instructions for use.

Nasal Spray 0.1%

10 ml of the drug in a frosted, translucent plastic bottle, equipped with a screw-on mechanical dispensing applicator with a protective cap and a plastic protective half ring to protect against accidental depression.

Each vial with instructions for use is placed in a cardboard box.

The drops are nasal.

Tablets, film-coated, 10 mg, 20 mg, 40 mg.

Tablets, film-coated

For 7 tablets in a blister of PVC / A1. 1 blister is placed in a cardboard box together with instructions for use. For 14 tablets in a blister of PVC / A1, 1, 2 or 6 blisters are placed in a cardboard box together with instructions for use.

Concentrate for solution for infusion, 10 mg / ml.

Tablets 50 mg.

Tablets are dispersible 125 mg, 250 mg, 500 mg, 1000 mg.

Capsules, 0.5 mg; 1.0 mg and 5.0 mg

10 capsules in a blister from Al / Al.

Tablets of prolonged action, film-coated, 0.4 mg.

For 10 tablets in blisters OPA / aluminum foil / PVC.

1, 2, 3, 5, 6, 9, 10, 20 blisters with instructions for use in a cardboard bundle.

For 7 tablets in blisters OPA / aluminum foil / PVC.

2, 4, 8 blisters with instructions for use in a cardboard pack.

Solution for intravenous and dermal administration, 60 million IU / ml.

Capsules 140 mg, 180 mg.

For 5 or 20 capsules in a dark glass bottle sealed with an aluminum membrane, with a polypropylene screw cap with child protection and first opening control.

1 bottle with instructions for use in a cardboard box.

140 mg, 180 mg.

For 5 or 20 capsules in a dark glass bottle sealed with an aluminum membrane, with a polypropylene screw cap with child protection and first opening control.

1 bottle with instructions for use in a cardboard box.

For 10 tablets in a PVC / aluminum blister.

For 2 or 3 blisters together with instructions for use in a cardboard bundle.

Tablets 250 mg

7 tablets in a blister made of polyvinyl chloride and aluminum foil.

For 1, 2 or 4 blisters together with instructions for use in a cardboard pack.

Capsules 200 mg and 400 mg.

Tablets of prolonged action, film-coated, 35 mg.

The tablets covered with a film cover of 20 mg.

Tablets of prolonged action, film-coated, 2.5 mg, 5 mg and 10 mg.

Dragee.

Tablets, film-coated, 5 mg.

Tablets 200 mg.

Tablets of prolonged action 200 mg, 400 mg.

A solution for intravascular and intracavitary administration of 250 mg / 5 ml, 500 mg / 10 ml, 1000 mg / 20 ml and 5000 mg / 100 ml (50 mg / ml)

The tablets covered with a film cover of 124 mg.

Tablets 50 mg.

Solution for infusions 2 mg / ml.

Film coated tablets, 250 mg and 500 mg.

Lyophilized powder for the preparation of an injection solution, 10 mg and 50 mg.

Tablets, film-coated 25 mg.

Tablets 2.5 mg, 5 mg, 10 mg, 20 mg.

Film-coated tablets, 25 mg and 50 mg.

Solution for intravenous and subcutaneous injection.

Tablets, film-coated, 5 mg, 10 mg, 20 mg.